Exosomes are having another moment in beauty. As the skincare industry increasingly focuses on regeneration, cellular signaling and long-term skin health, these microscopic messengers are becoming one of the most talked-about ingredients in advanced skincare.
But for Dr. Ivona Igerc, known as Dr. Ivy, the conversation around skin regeneration is hardly new.
The London-based Harley Street aesthetic doctor has more than 28 years of experience in aesthetic medicine and has built her own skincare brand, Dr Ivy Skincare, around a regenerative approach to skin health.
The renewed interest in exosomes comes as beauty consumers look beyond traditional anti-aging claims and toward products designed to support healthier-looking skin over time. Vogue recently explored the future of exosome skincare, examining the technology’s growing role in conversations about cellular communication, regeneration and skin longevity.
Dr. Ivy brings a unique perspective to that conversation as both a physician and skincare founder. Her approach combines her experience in aesthetic medicine with products designed to make regenerative skincare part of a daily routine.
The Dr Ivy Skincare collection currently features three core products: the Regenerative Exosome Cleanser, Regenerative Exosome Serum and Regenerative Exosome Face Cream. Together, the products are positioned as a three-step regimen focused on cleansing, treatment and hydration while supporting a more rejuvenated-looking complexion.
The growing interest in exosomes also reflects a larger shift in the beauty industry. Consumers are increasingly interested in the science behind their skincare and are asking questions about ingredients, skin longevity and the technologies driving the next generation of beauty products.
For Dr. Ivy, that evolution represents an opportunity to move the conversation beyond simply looking younger.
Her philosophy centers on taking a longer-term view of skin health and incorporating advanced skincare concepts into everyday routines. That perspective places her at the intersection of aesthetic medicine, beauty technology and consumer skincare—three areas that continue to converge as the industry evolves.
With exosomes once again commanding attention from beauty media and consumers, Dr. Ivy is well positioned to contribute to the conversation about what comes next.
Her experience also offers a reminder that trends in beauty often build on ideas that practitioners and innovators have been exploring for years. As regenerative skincare moves further into the mainstream, the focus may increasingly shift from quick fixes to understanding how technology, ingredients and consistent skincare routines can work together to support healthier-looking skin.